Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque
- 15 April 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (8) , 2794-2800
- https://doi.org/10.1182/blood.v99.8.2794
Abstract
Defined angiographically, no-reflow (NR) manifests as an acute reduction in coronary flow in the absence of epicardial vessel obstruction. One candidate protein to cause coronary NR is tissue factor (TF), which is abundant in atherosclerotic plaque and a cofactor for activated plasma coagulation factor VII. Scrapings from atherosclerotic carotid arteries contained TF activity (corresponding to 33.03 ± 13.00 pg/cm2 luminal plaque surface). Active TF was sedimented, indicating that TF was associated with membranes. Coronary blood was drawn from 6 patients undergoing coronary interventions with the distal protection device PercuSurge GuardWire (Traatek, Miami, FL). Fine particulate material that was recovered from coronary blood showed TF activity (corresponding to 91.1 ± 62.16 pg/mL authentic TF). To examine the role of TF in acute coronary NR, blood was drawn via a catheter from coronary vessels in 13 patients during NR and after restoration of flow. Mean TF antigen levels were elevated during NR (194.3 ± 142.8 pg/mL) as compared with levels after flow restoration (73.27 ± 31.90 pg/mL; P = .02). To dissect the effects of particulate material and purified TF on flow, selective intracoronary injection of atherosclerotic material or purified relipidated TF was performed in a porcine model. TF induced NR in the model, thus strengthening the concept that TF is causal, not just a bystander to atherosclerotic plaque material. The data suggest that active TF is released from dissected coronary atherosclerotic plaque and is one of the factors causing the NR phenomenon. Thus, blood-borne TF in the coronary circulation is a major determinant of flow.Keywords
This publication has 36 references indexed in Scilit:
- Inhibition of the Tissue Factor-Thrombin Pathway Limits Infarct Size after Myocardial Ischemia-Reperfusion Injury by Reducing InflammationThe American Journal of Pathology, 2000
- Endothelium‐dependent contractile actions of proteinase‐activated receptor‐2‐activating peptides in human umbilical vein: release of a contracting factor via a novel receptorBritish Journal of Pharmacology, 1998
- Thrombin-induced vasospasm: Cellular signaling mechanismsSurgery, 1998
- Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein graftsThe American Journal of Cardiology, 1997
- Features and outcome of no-reflow after percutaneous coronary interventionThe American Journal of Cardiology, 1995
- Tissue factor contributes to microvascular defects after focal cerebral ischemia.Stroke, 1993
- Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymic activity of the complexBiochemistry, 1992
- Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserineBiochemistry, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Species Specificity of Tissue ThromboplastinPathophysiology of Haemostasis and Thrombosis, 1984